Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Unternehmen & Branche
| Name | VIEMED HEALTHCARE, INC. |
|---|---|
| Ticker | VMD |
| CIK | 0001729149 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 8090 · Services-Misc Health & Allied Services, NEC |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 385,2 Mio. USD |
| Beta | 1,16 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 270,280,000 | 14,934,000 | 0.37 | 199,154,000 | 141,545,000 |
| 2025-09-30 | 10-Q | 71,914,000 | 3,513,000 | 0.09 | 202,360,000 | 133,608,000 |
| 2025-06-30 | 10-Q | 63,056,000 | 3,157,000 | 0.08 | 184,603,000 | 139,731,000 |
| 2025-03-31 | 10-Q | 59,129,000 | 2,625,000 | 0.06 | 178,079,000 | 134,756,000 |
| 2024-12-31 | 10-K | 224,257,000 | 11,265,000 | 0.28 | 177,069,000 | 131,393,000 |
| 2024-09-30 | 10-Q | 58,004,000 | 3,878,000 | 0.10 | 169,526,000 | 124,959,000 |
| 2024-06-30 | 10-Q | 54,965,000 | 1,468,000 | 0.04 | 163,947,000 | 119,371,000 |
| 2024-03-31 | 10-Q | 50,593,000 | 1,603,000 | 0.04 | 154,875,000 | 116,273,000 |
| 2023-12-31 | 10-K | 183,008,000 | 10,243,000 | 0.25 | 154,895,000 | 113,895,000 |
| 2023-09-30 | 10-Q | 49,402,000 | 2,919,000 | 0.07 | 149,400,000 | 108,814,000 |
| 2023-06-30 | 10-Q | 43,311,000 | 2,330,000 | 0.06 | 149,117,000 | 104,505,000 |
| 2023-03-31 | 10-Q | 39,556,000 | 1,517,000 | 0.04 | 124,634,000 | 100,041,000 |
| 2022-12-31 | 10-K | 138,832,000 | 6,222,000 | 0.16 | 117,043,000 | 97,094,000 |
| 2022-09-30 | 10-Q | 35,759,000 | 1,055,000 | 0.03 | 119,419,000 | 93,909,000 |
| 2022-06-30 | 10-Q | 33,310,000 | 967,000 | 0.02 | 115,904,000 | 93,227,000 |
| 2022-03-31 | 10-Q | 32,255,000 | 1,762,000 | 0.04 | 119,007,000 | 96,044,000 |
| 2021-12-31 | 10-K | 117,062,000 | 9,126,000 | 0.22 | 117,962,000 | 94,820,000 |
| 2021-09-30 | 10-Q | 29,285,000 | 1,789,000 | 0.04 | 115,486,000 | 89,376,000 |
| 2021-06-30 | 10-Q | 27,399,000 | 1,566,000 | 0.04 | 111,014,000 | 86,264,000 |
| 2021-03-31 | 10-Q | 28,416,000 | 1,684,000 | 0.04 | 113,001,000 | 83,421,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | Moore Michael | Officer, President | Open Market Sale | -65,000 | 8.77 | -570,050.00 | -210,7% | |
| 2026-03-19 | Moore Michael | Officer, President | Open Market Sale | -40,232 | 9.21 | -370,536.72 | -137,0% | |
| 2026-03-18 | Moore Michael | Officer, President | Open Market Sale | -31,570 | 9.42 | -297,389.40 | -109,9% | |
| 2025-08-13 | Cambre Jerome | Officer, Vice President of Sales | Open Market Sale | -1,580 | 7.33 | -11,581.40 | -4,3% | |
| 2025-08-13 | Cambre Jerome | Officer, Vice President of Sales | Open Market Sale | -3,300 | 7.32 | -24,156.00 | -8,9% | |
| 2025-08-12 | Moore Michael | Officer, President | Open Market Sale | -50,090 | 7.33 | -367,159.70 | -135,7% | |
| 2025-06-30 | Kaushal Nitin | Director | Open Market Sale | -7,048 | 6.91 | -48,701.68 | -18,0% | |
| 2025-06-30 | Moore Michael | Officer, President | Open Market Sale | -127,053 | 6.92 | -879,206.76 | -325,0% | |
| 2025-06-30 | Moore Michael | Officer, President | Open Market Sale | -50,777 | 6.93 | -351,884.61 | -130,1% | |
| 2025-06-27 | Moore Michael | Officer, President | Open Market Sale | -3,486 | 7.00 | -24,402.00 | -9,0% | |
| 2025-06-27 | Kaushal Nitin | Director | Open Market Sale | -34,100 | 7.01 | -239,041.00 | -88,4% | |
| 2025-06-26 | Kaushal Nitin | Director | Open Market Sale | -8,852 | 7.00 | -61,964.00 | -22,9% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.